Certain genetic mutations and abnormalities are associated with an increased risk of AML, such as chromosomal abnormalities (e.g., t(8; 21), t(15;17)) and gene mutations (e.g., FLT3, NPM1, DNMT3A). The gene discussed is FLT3; the disease is acute myeloid leukemia.